Eli Lilly and Co LLY Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	47.06B	47.46B	49.49B	53.16B	54.81B	57.92B	64.01B	63.94B
Total Current Assets	17.12B	17.64B	18.03B	20.81B	21.33B	23.01B	25.73B	25.19B
Cash and Equivalents	2.62B	2.62B	2.07B	3.55B	2.69B	2.38B	2.82B	2.46B
Total Non-Current Assets	39.08B	39.13B	41.6B	42.9B	44.76B	46.77B	51.19B	52.38B
Total Liabilities	38.4B	37.3B	38.71B	41.87B	43.66B	46.61B	53.14B	51.05B
Total Current Liabilities	15.62B	15.65B	17.14B	16.01B	18.92B	22B	27.29B	18.6B
Total Non-Current Liabilities	37.48B	35.79B	36.31B	44.74B	42.91B	42.53B	44.17B	57.01B
Common Equity	594.1M	594.1M	594.1M	593.5M	593.6M	593.6M	593.6M	594.2M
Retained Earnings	8.56B	10.01B	10.04B	10.64B	10.37B	10.31B	10.31B	12.55B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	38.81B	44.98B	43.91B	39.29B	46.63B	48.81B	49.49B	64.01B
Total Current Assets	15.1B	19.2B	20.55B	13.71B	17.46B	18.45B	18.03B	25.73B
Cash and Equivalents	4.58B	6.54B	8B	2.34B	3.66B	3.82B	2.07B	2.82B
Total Non-Current Assets	14.08B	11.67B	10.91B	2.7B	5.83B	9.15B	10.78B	10.86B
Total Liabilities	24.73B	33.31B	33B	36.59B	40.81B	39.65B	38.71B	53.14B
Total Current Liabilities	10.99B	14.54B	11.89B	11.78B	12.48B	15.05B	17.14B	27.29B
Total Non-Current Liabilities	22.11B	28.72B	32.75B	38.63B	44.91B	39.94B	36.31B	44.17B
Total Equity	14.08B	11.67B	10.91B	2.7B	5.83B	9.15B	10.78B	10.86B
Common Equity	688.5M	687.9M	661M	598.8M	598.2M	596.3M	594.1M	593.6M
Retained Earnings	16.05B	13.89B	11.4B	4.92B	7.83B	8.96B	10.04B	10.31B